M. Andres Blanco, an assistant professor, in biomedical sciences at Penn Vet, was recently awarded a $100,000 grant from The Leukemia Research Foundation for blood cancer research funding to for the research project titled “Dual Targeting of LSD1 and KAT6A to Induce Therapeutic Differentiation in AML.” The one-year grant is awarded through the Foundation’s Hollis Brownstein Research Grants Program for New Investigators.

“The primary mission of the Leukemia Research Foundation is to fund research into the causes of and cures for blood cancers and providing grants to New Investigators is critically important,” said Leukemia Research Foundation Executive Director Kevin Radelet.

Each proposal was thoroughly evaluated and scored using the same scoring system adhered to by the NIH. The Leukemia Research Foundation Medical Advisory Board, led by Patrick J. Stiff, medical director of the Cardinal Bernardin Cancer Center at Loyola University Medical Center in Maywood, Illinois, discussed each project in person that scored in the top half of the preliminary critique. Final recommendations were forwarded to the Leukemia Research Foundation for funding.